Lantheus Biosciences Ltd.
Nasdaq LNTH · Bedford, MA
Works in Neurology · Psychiatry
Lantheus Biosciences Ltd. is a clinical trial sponsor based in Bedford, MA, listed as Nasdaq LNTH. It has 1 active clinical trial with 200 planned participants, in Neurology and Psychiatry. Since 2021 it has completed 3 trials and stopped 1 early.
Trial track record · since 2021
Financials · Nasdaq LNTH
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
On the market
1 approved drug application with a product on the market.
Questions about Lantheus Biosciences Ltd
Lantheus Biosciences Ltd is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 200 planned participants, in Neurology, Psychiatry. Since 2021 it has completed 3 trials and stopped 1 early.
Lantheus Biosciences Ltd is based in Bedford, MA and is listed as Nasdaq LNTH. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Lantheus Biosciences Ltd; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-26.
Approve Suite is not affiliated with Lantheus Biosciences Ltd..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.